Clinton Health Access Initiative Inc.
28
4
7
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 28 trials
100.0%
+13.5% vs industry average
4%
1 trials in Phase 3/4
11%
2 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children
Role: collaborator
PathToScale: The PERSIST Trial
Role: collaborator
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia
Role: collaborator
DSD Models at Zambia Sentinel Sites (SENTINEL 2)
Role: collaborator
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Role: collaborator
Gathering Records to Evaluate Antiretroviral Treatment-Malawi ( GREAT )
Role: collaborator
Gathering Records to Evaluate Antiretroviral Treatment-Zambia (GREAT )
Role: collaborator
Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia
Role: collaborator
Private Medicine Retailer-based Trial of Malaria Tests and Conditional Treatment Subsidies Among Patients With Fever
Role: lead
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Zambia
Role: collaborator
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Malawi
Role: collaborator
Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)
Role: collaborator
Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country Evaluation
Role: collaborator
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Nigeria
Role: collaborator
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Kenya
Role: collaborator
Therapy Strategies After LAA Occluder Device Embolization
Role: collaborator
Cameroon HepB Birth Dose Feasibility Pilot
Role: lead
Community Access to Rectal Artesunate for Malaria
Role: collaborator
Impact of Point-of-care (POC) Viral Load (VL) Testing During Pregnancy in Zimbabwe
Role: lead
PrEP Demonstration Study in Swaziland
Role: lead